TH
IONS icon

Timber Hill’s Ionis Pharmaceuticals IONS Stock Holding History

Timber Hill’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,500
Closed -$422K – 1347
2017
Q1 		$422K Sell
10,500
-17,300
-62% -$777K ﹤0.01% 1566
2016
Q4 		$1.33M Buy
27,800
+15,100
+119% +$597K 0.01% 1117
2016
Q3 		$465K Buy
12,700
+3,700
+41% +$116K ﹤0.01% 1511
2016
Q2 		$210K Sell
9,000
-27,700
-75% -$894K ﹤0.01% 1970
2016
Q1 		$1.49M Buy
36,700
+19,500
+113% +$792K 0.01% 1076
2015
Q4 		$1.06M Sell
17,200
-72,300
-81% -$3.9M 0.01% 1311
2015
Q3 		$3.62M Buy
89,500
+44,400
+98% +$2.3M 0.02% 704
2015
Q2 		$2.6M Buy
45,100
+5,600
+14% +$356K 0.01% 930
2015
Q1 		$2.52M Sell
39,500
-7,100
-15% -$482K 0.01% 908
2014
Q4 		$2.88M Sell
46,600
-29,200
-39% -$1.44M 0.01% 819
2014
Q3 		$2.94M Sell
75,800
-500
-0.7% -$17.7K 0.01% 897
2014
Q2 		$2.63M Sell
76,300
-37,200
-33% -$1.17M 0.01% 996
2014
Q1 		$4.9M Buy
113,500
+43,000
+61% +$2.08M 0.02% 650
2013
Q4 		$2.81M Sell
70,500
-8,700
-11% -$310K 0.01% 1130
2013
Q3 		$2.97M Buy
79,200
+22,500
+40% +$672K 0.01% 1179
2013
Q2 		$1.52M Buy
+56,700
New +$1.21M 0.01% 1632

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Timber Hill's IONS Position: Q1 2017 in Review

Timber Hill sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 8,721 shares — an estimated $392K sold.

Timber Hill first reported a position in IONS in Q2 2013 and held it in 7 quarters. The position peaked at $1.02M in Q3 2016. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

  • Timber Hill reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Timber Hill sold 8,721 Ionis Pharmaceuticals shares in Q1 2017, an estimated $392K.
  • Timber Hill first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Timber Hill's Ionis Pharmaceuticals position peaked at $1.02M in Q3 2016.
  • 270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Timber Hill's 13F filing for Q1 2017, filed 10 May 2017.